A micromethod for the measurement of human plasma renin activity. 1973

J Jelínek, and P Karen, and I Pohlová, and I Zofková

UI MeSH Term Description Entries
D008297 Male Males
D008722 Methods A series of steps taken in order to conduct research. Techniques,Methodological Studies,Methodological Study,Procedures,Studies, Methodological,Study, Methodological,Method,Procedure,Technique
D008846 Micromanipulation The performance of dissections, injections, surgery, etc., by the use of micromanipulators (attachments to a microscope) that manipulate tiny instruments. Micromanipulations
D009392 Nephrectomy Excision of kidney. Heminephrectomy,Heminephrectomies,Nephrectomies
D012083 Renin A highly specific (Leu-Leu) endopeptidase that generates ANGIOTENSIN I from its precursor ANGIOTENSINOGEN, leading to a cascade of reactions which elevate BLOOD PRESSURE and increase sodium retention by the kidney in the RENIN-ANGIOTENSIN SYSTEM. The enzyme was formerly listed as EC 3.4.99.19. Angiotensin-Forming Enzyme,Angiotensinogenase,Big Renin,Cryorenin,Inactive Renin,Pre-Prorenin,Preprorenin,Prorenin,Angiotensin Forming Enzyme,Pre Prorenin,Renin, Big,Renin, Inactive
D005246 Feedback A mechanism of communication within a system in that the input signal generates an output response which returns to influence the continued activity or productivity of that system. Feedbacks
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D006863 Hydrogen-Ion Concentration The normality of a solution with respect to HYDROGEN ions; H+. It is related to acidity measurements in most cases by pH pH,Concentration, Hydrogen-Ion,Concentrations, Hydrogen-Ion,Hydrogen Ion Concentration,Hydrogen-Ion Concentrations
D000804 Angiotensin II An octapeptide that is a potent but labile vasoconstrictor. It is produced from angiotensin I after the removal of two amino acids at the C-terminal by ANGIOTENSIN CONVERTING ENZYME. The amino acid in position 5 varies in different species. To block VASOCONSTRICTION and HYPERTENSION effect of angiotensin II, patients are often treated with ACE INHIBITORS or with ANGIOTENSIN II TYPE 1 RECEPTOR BLOCKERS. Angiotensin II, Ile(5)-,Angiotensin II, Val(5)-,5-L-Isoleucine Angiotensin II,ANG-(1-8)Octapeptide,Angiotensin II, Isoleucine(5)-,Angiotensin II, Valine(5)-,Angiotensin-(1-8) Octapeptide,Isoleucine(5)-Angiotensin,Isoleucyl(5)-Angiotensin II,Valyl(5)-Angiotensin II,5 L Isoleucine Angiotensin II,Angiotensin II, 5-L-Isoleucine
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia

Related Publications

J Jelínek, and P Karen, and I Pohlová, and I Zofková
September 1972, Klinische Wochenschrift,
J Jelínek, and P Karen, and I Pohlová, and I Zofková
June 1976, The Medical journal of Malaysia,
J Jelínek, and P Karen, and I Pohlová, and I Zofková
September 1967, Canadian journal of physiology and pharmacology,
J Jelínek, and P Karen, and I Pohlová, and I Zofková
November 1965, Circulation research,
J Jelínek, and P Karen, and I Pohlová, and I Zofková
June 1969, The Tohoku journal of experimental medicine,
J Jelínek, and P Karen, and I Pohlová, and I Zofková
January 1967, Helvetica physiologica et pharmacologica acta,
J Jelínek, and P Karen, and I Pohlová, and I Zofková
January 2013, Methods in molecular biology (Clifton, N.J.),
J Jelínek, and P Karen, and I Pohlová, and I Zofková
January 2006, Methods in molecular biology (Clifton, N.J.),
J Jelínek, and P Karen, and I Pohlová, and I Zofková
April 1971, Nihon Hinyokika Gakkai zasshi. The japanese journal of urology,
J Jelínek, and P Karen, and I Pohlová, and I Zofková
February 1971, Nihon Hinyokika Gakkai zasshi. The japanese journal of urology,
Copied contents to your clipboard!